TRANSLATION TO CLINIC CONCURRENT Advancing iPSCs for Clinical Use
Thursday, June 1, 2023 03:45 PM - 04:45 PM
Amphitheatre Bleu
TRANSLATION TO CLINIC
Concurrent
Chair
Jacqueline Barry, PhD, Chief Clinical Officer, Cell and Gene Therapy Catapult, UK
Speakers
Tenneille Ludwig, PhD, Director, WiCell Stem Cell Bank, USA
Massimiliano Gnecchi, MD, PhD, FESC, Professor, University of Pavia & Fondazione IRCCS Policlinico San Matteo, Italy
Kapil Bharti, PhD, Senior Investigator, National Institutes of Health, USA
Session Description
Induced Pluripotent Stem Cell offer unique potential for the development of advanced therapies, however they also have very specific scientific and regulatory challenges. The session will explore quality, preclinical and clinical trials considerations of iPSC master cell banks and products developed from these.
Jacqueline Barry, PhD, Chief Clinical Officer, Cell and Gene Therapy Catapult, UK
Speakers
Tenneille Ludwig, PhD, Director, WiCell Stem Cell Bank, USA
Massimiliano Gnecchi, MD, PhD, FESC, Professor, University of Pavia & Fondazione IRCCS Policlinico San Matteo, Italy
Kapil Bharti, PhD, Senior Investigator, National Institutes of Health, USA
Session Description
Induced Pluripotent Stem Cell offer unique potential for the development of advanced therapies, however they also have very specific scientific and regulatory challenges. The session will explore quality, preclinical and clinical trials considerations of iPSC master cell banks and products developed from these.
Massimiliano Gnecchi MD, PhD, FESC
Professor
University of Pavia & Fondazione IRCCS Policlinico San Matteo
Speaker
Professor
University of Pavia & Fondazione IRCCS Policlinico San Matteo
Speaker